Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06315491
Status:
RECRUITING
Last Update Posted:
2024-03-18
First Post:
2024-03-07
Brief Title:
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Sponsor:
Cybrexa Therapeutics
Organization:
Cybrexa Therapeutics
Organization Data
Organization:
Cybrexa Therapeutics
Class:
INDUSTRY
Study ID:
CBX-12-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cybrexa Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None